1. Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection.
- Author
-
Sester M, Giehl C, McNerney R, Kampmann B, Walzl G, Cuchí P, Wingfield C, Lange C, Migliori GB, Kritski AL, and Meyerhans A
- Subjects
- AIDS Vaccines therapeutic use, Comorbidity, Congresses as Topic, Europe, Female, Group Processes, HIV Infections diagnosis, HIV Infections epidemiology, Health Planning Guidelines, Humans, Male, Mycobacterium tuberculosis isolation & purification, Tuberculosis Vaccines therapeutic use, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary epidemiology, Anti-HIV Agents therapeutic use, Antitubercular Agents therapeutic use, HIV Infections drug therapy, Mycobacterium tuberculosis drug effects, Tuberculosis, Pulmonary drug therapy
- Abstract
HIV and Mycobacterium tuberculosis (MTB) are two widespread and highly successful microbes whose synergy in pathogenesis has created a significant threat for human health globally. In acknowledgement of this fact, the European Union (EU) has funded a multinational support action, the European Network for global cooperation in the field of AIDS and TB (EUCO-Net), that brings together experts from Europe and those regions that bear the highest burden of HIV/MTB co-infection. Here, we summarise the main outcome of the EUCO-Net project derived from an expert group meeting that took place in Stellenbosch (South Africa) (AIDS/TB Workshop on Research Challenges and Opportunities for Future Collaboration) and the subsequent discussions, and propose priority areas for research and concerted actions that will have impact on future EU calls.
- Published
- 2010
- Full Text
- View/download PDF